• Markets
    • News
    • Tech
    • Market Movers
    • Futures Forex
    • Macroeconomic Predictions
    • Options
  • Insider Trading
    • Main
    • Education Center
    • Stock Screener
    • Insider Purchases
    • Insider Sales
    • Browse Companies
    • Latest 13D & 13G Filings
  • Hedge Funds
    • Main
    • Education Center
    • Browse Hedge Funds
    • Best Performing
    • Worst Performing
    • Other Institutional Investors
  • Retirement
    • ETF Trading
    • Commodities
    • Gold
    • Dividend Stocks
  • Opinion
    • Main
    • Hedge Fund Analysis
    • Stock Analysis
    • We Disagree
    • Lists
    • Authors
  • Premium
    • Newsletters
    • My Subscriptions
    • Premium Readership
  • Log In
  • Sign Up
Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for Sorry, no results has been found matching your query.

Posts Tagged ‘RA Capital Management’

Countries with the Smallest Government Per Capita in the World

Hedge Fund and Insider Trading News: Bill Ackman, Steven A. Cohen, Tom Steyer, RA Capital Management, Healthequity Inc (HQY), Tel-Instrument Electronics Corp. (TIKK), and More

Ackman’s London-Listed Pershing Square Gets Its Own Activist (Bloomberg) Bill Ackman’s publicly-traded Pershing Square Holdings Ltd. has an activist...

Keep Reading →

July 16 - Hedge Funds, Insider Trading - Comments

RA Capital Management Bets Another $20 Million On Kala Pharmaceuticals Inc.

Peter Kolchinsky’s RA Capital purchased $20 million of Kala Pharmaceuticals Inc. (KALA) shares. The details of the transaction can be seen below...

Keep Reading →

October 8 - Hedge Funds, Insider Trading, News - Comments

This Biotech Investor’s Picks Returned 31% in Q1; Here Are Its New Bets

Peter Kolchinsky is one of the best biotech investors and many of his stock picks generate strong returns. We calculate a fund’s returns by taking...

Keep Reading →

June 12 - Hedge Funds, News - Comments

Five Stocks To Buy According To Top Biotech-Focused Funds

Biotechnology is a very interesting industry to invest in, but also very complex. If you are looking for stocks that are most likely to see their value...

Keep Reading →

May 1 - Hedge Funds, News - Comments

pharmacist, worker, shelves, business, counter, glasses, attractive, medical, competence, chemist, adult, clinic, drugstore, selling, female, consultation, medicine, coat

13D Filing: RA Capital Management and Biocryst Pharmaceuticals Inc (BCRX)

Biocryst Pharmaceuticals Inc (NASDAQ:BCRX): Peter Kolchinsky’s RA Capital Management filed an amended 13D. You can check out RA Capital Management...

Keep Reading →

April 3 - Hedge Funds - Comments

easiest countries to get oxycodone prescribed

13D Filing: RA Capital Management and Dicerna Pharmaceuticals Inc (DRNA)

Dicerna Pharmaceuticals Inc (NASDAQ:DRNA): Peter Kolchinsky’s RA Capital Management filed an amended 13D. You can check out RA Capital Management...

Keep Reading →

March 28 - Hedge Funds - Comments

people, person, lab, nuclear, hydrogen, concept, chemistry, technicians, researching, formula, chemists, biotechnology, researchers, discovery, weapon, samples,

13D Filing: RA Capital Management and Solid Biosciences Inc (SLDB)

Solid Biosciences Inc (NASDAQ:SLDB): Peter Kolchinsky’s RA Capital Management filed an amended 13D. You can check out RA Capital Management’...

Keep Reading →

February 12 - Hedge Funds - Comments

Countries with Highest Natural Gas Reserves

Big Insider Buying at Hot IPO Solid Biosciences (SLDB), Range Resources (RRC) and General Electric (GE)

With the stock market having been battered in recent days and fears that a large correction may be starting to pick up steam becoming more pronounced,...

Keep Reading →

February 5 - Hedge Funds, Insider Trading, Market Movers, News - Comments

pharmacist, worker, shelves, business, counter, glasses, attractive, medical, competence, chemist, adult, clinic, drugstore, selling, female, consultation, medicine, coat

13D Filing: RA Capital Management and Dicerna Pharmaceuticals Inc (DRNA)

Dicerna Pharmaceuticals Inc (NASDAQ:DRNA): Peter Kolchinsky’s RA Capital Management filed an amended 13D. You can check out RA Capital Management...

Keep Reading →

January 26 - Hedge Funds - Comments

pharmacist, worker, shelves, business, counter, glasses, attractive, medical, competence, chemist, adult, clinic, drugstore, selling, female, consultation, medicine, coat

13D Filing: RA Capital Management and Dicerna Pharmaceuticals Inc (DRNA)

Dicerna Pharmaceuticals Inc (NASDAQ:DRNA): Peter Kolchinsky’s RA Capital Management filed an amended 13D. You can check out RA Capital Management...

Keep Reading →

December 22 - Hedge Funds - Comments

10 Pharmacist Shortage Countries in Need of Pharmacists in 2017

13D Filing: RA Capital Management and Dicerna Pharmaceuticals Inc (DRNA)

Dicerna Pharmaceuticals Inc (NASDAQ:DRNA): Peter Kolchinsky’s RA Capital Management filed an amended 13D. You can check out RA Capital Management...

Keep Reading →

December 18 - Hedge Funds - Comments

13G Filing: RA Capital Management and Scpharmaceuticals Inc (SCPH)

Scpharmaceuticals Inc (NASDAQ:SCPH): Peter Kolchinsky’s RA Capital Management filed an amended 13D. You can check out RA Capital Management’...

Keep Reading →

December 12 - Hedge Funds - Comments

biotech research company, bio-technology companies

13G Filing: RA Capital Management and Inflarx NV (IFRX)

Inflarx NV (NASDAQ:IFRX): Peter Kolchinsky’s RA Capital Management filed an amended 13D. You can check out RA Capital Management’s latest...

Keep Reading →

December 12 - Hedge Funds - Comments

Healthcare Careers That Require a Master’s Degree

13D Filing: RA Capital Management and Wave Life Sciences Ltd (WVE)

Wave Life Sciences Ltd (NASDAQ:WVE): Peter Kolchinsky’s RA Capital Management filed an amended 13D. You can check out RA Capital Management’...

Keep Reading →

November 20 - Hedge Funds - Comments

easiest countries to get oxycodone prescribed

13G Filing: RA Capital Management and Sunesis Pharmaceuticals Inc (SNSS)

Sunesis Pharmaceuticals Inc (NASDAQ:SNSS): Peter Kolchinsky’s RA Capital Management filed an amended 13D. You can check out RA Capital Management...

Keep Reading →

November 14 - Hedge Funds - Comments

13D Filing: RA Capital Management and Kalvista Pharmaceuticals Inc. (KALV)

Kalvista Pharmaceuticals Inc. (NASDAQ:KALV): Peter Kolchinsky’s RA Capital Management filed an amended 13D. You can check out RA Capital Management...

Keep Reading →

November 14 - Hedge Funds - Comments

13D Filing: RA Capital Management and Dicerna Pharmaceuticals Inc (DRNA)

You can access the original SEC filing by clicking here. Ownership Summary Table Page 1 of 9 – SEC Filing UNITED STATES SECURITIES AND EXCHANGE...

Keep Reading →

April 13 - Hedge Funds - Comments

Avexis Inc. (AVXS): RA Capital Management Ups Its Stake

Peter Kolchinsky‘s RA Capital Management has slightly raised its stake in Avexis Inc. (NASDAQ:AVXS), as per a new Form 13G with the Securities...

Keep Reading →

December 27 - Hedge Funds, News - Comments

RA Capital Management Slashes Alcobra Ltd (ADHD) Position After FDA Clinical Hold

Peter Kolchinsky‘s RA Capital Management has slashed its position in Alcobra Ltd (NASDAQ:ADHD) to just under 1.31 million shares according to a...

Keep Reading →

October 23 - Hedge Funds, News - Comments

Aclaris Therapeutics Inc (ACRS): RA Capital Management Disposes of 1.1 Million Shares

An amended 13G filing with the SEC revealed that Peter Kolchinsky‘s RA Capital Management has sold around 1.1 million shares of Aclaris Therapeutics...

Keep Reading →

October 7 - Hedge Funds, News - Comments

Protagonist Therapeutics Inc (PTGX): RA Capital Management Acquires 6.8% Stake

Peter Kolchinsky‘s RA Capital Management reported via a recent 13G filing with the SEC that it has taken a new position in a company that has recently...

Keep Reading →

August 26 - Hedge Funds, News - Comments

Vitae Pharmaceuticals Inc (VTAE): RA Capital Management Ups Its Stake

A recent 13G filing with the SEC revealed that Peter Kolchinsky‘s RA Capital Management has acquired more shares of Vitae Pharmaceuticals Inc...

Keep Reading →

August 16 - Hedge Funds, News - Comments

BPMC

Ardelyx (ARDX): RA Capital Management Boosts Stake to 7.7%

Peter Kolchinsky‘s RA Capital Management has stepped up its interest in Ardelyx Inc. (NASDAQ:ARDX). As reported in a recent filing with the Securities...

Keep Reading →

July 29 - Hedge Funds, News - Comments

Peter Kolchinsky Is Betting Big On Achillion Pharmaceuticals, Inc. (ACHN), Wave Life Sciences (WVE) & More Heading Into 2016

Peter Kolchinsky founded RA Capital Management in 2001 and focuses mainly on healthcare stocks. One of the few hedge fund managers who actually holds...

Keep Reading →

February 25 - Hedge Funds, News - Comments

13G Filing: RA Capital Management and Derma Sciences, Inc. (DSCI)

In a new filing with the Securities and Exchange Commission, Peter Kolchinsky‘s RA Capital Management disclosed a position in Derma Sciences Inc...

Keep Reading →

February 1 - Hedge Funds, News - Comments

Dalton Investments Proposes 6-Point Action Plan to Eros, While Eminence Capital Reveals New Stake in This Hotel Operator

The practice of monitoring quarterly 13F filings has become more popular in recent years, which led to several exchange traded funds (ETFs) being launched...

Keep Reading →

November 30 - Hedge Fund Analysis, Hedge Funds, News - Comments

Two Activist Plays And Two Biotech Moves You Should Check Out

With hedge funds having submitted their 13F filings for the third quarter, people at Insider Monkey are busy compiling the data necessary to identify...

Keep Reading →

November 20 - Hedge Funds, News - Comments

James Flynn Deerfield Management

Sequenom, Aclaris, and Xenoport Making Waves Among Elite Healthcare Investors

Three prominent healthcare-focused funds that we track at Insider Monkey submitted filings with the SEC today, disclosing new or bulked up positions in...

Keep Reading →

October 13 - Hedge Funds, News - Comments

Is Zogenix A Good Stock To Buy Now?

RA Capital Management, led by Peter Kolchinsky, has disclosed a massive new stake in California-based pharmaceutical company Zogenix, Inc (NASDAQ:ZGNX...

Keep Reading →

October 9 - Hedge Funds, News - Comments

Steve Cohen, Peter Kolchinsky Disclose New Stakes In Micro-cap Pharmaceutical Stocks

Steve Cohen’s Point72 Asset Management has initiated a new position in Inotek Pharmaceuticals Corporation (NASDAQ:ITEK). In a freshly-submitted filing...

Keep Reading →

August 25 - Hedge Funds, News - Comments

Peter Kolchinsky’s New Top Healthcare Pick And Old Favorites

Peter Kolchinsky‘s RA Capital Management recently filed its 13F with the SEC for the reporting period of June 30. Peter Kolchinsky started RA Capital...

Keep Reading →

August 15 - Hedge Fund Analysis, Hedge Funds, News - Comments

Ardelyx Inc (ARDX): RA Capital Management Discloses 7.3% Passive Stake

RA Capital Management, led by Peter Kolchinsky, has opened a new position in clinical-stage biopharmaceutical company Ardelyx Inc (NASDAQ:ARDX). A new...

Keep Reading →

June 7 - Hedge Funds, News - Comments

Chase Coleman Tiger Global Management

Bitauto Hldg Ltd (ADR) (BITA), Aurinia Pharmaceuticals Inc (AUPH): Tiger Global and RA Capital Disclose Their Latest Moves

In a new filing with the Securities and Exchange Commission, Billionaire Chase Coleman‘s Tiger Global disclosed slightly reducing its exposure...

Keep Reading →

March 27 - Hedge Funds, News, Tech - Comments

Regulus Therapeutics Inc (RGLS), Trevena Inc (TRVN), Juno Therapeutics Inc (JUNO): RA Capital’s Top New Biotech Picks

Peter Kolchinsky’s RA Capital Management filed its latest 13F with the Securities and Exchange Commission in February, and we’ve gone through the...

Keep Reading →

March 4 - Hedge Funds, News - Comments

Felix Baker - Baker Bros.

Seattle Genetics Inc. (SGEN), Cerus Corporation (CERS): Baker Bros. Advisors’ Latest Moves

Baker Bros. Advisors, the fund managed by Julian and Felix Baker disclosed changes in two of its activist positions last Thursday. The firm continued...

Keep Reading →

December 15 - Hedge Funds, News - Comments

Synergy Pharmaceuticals Inc (SGYP), Proteon Therapeutics Inc (PRTO): James E. Flynn and Peter Kolchinsky Think These Stocks Look Healthy

Synergy Pharmaceuticals Inc (NASDAQ:SGYP) and Proteon Therapeutics Inc (NASDAQ:PRTO) are in the spotlight as James E. Flynn’s Deerfield Management and...

Keep Reading →

November 3 - Hedge Funds, News - Comments

Entegris Inc (NASDAQ:ENTG)

Entegris Inc (ENTG), Dicerna Pharmaceuticals Inc (DRNA): GMT Capital and Deerfield Management Report Their Latest Moves

In two new filings, Thomas E. Claugus‘ GMT Capital disclosed further raising its exposure to Entegris Inc (NASDAQ:ENTG). The investor revealed buying...

Keep Reading →

October 16 - Hedge Funds, News, Tech - Comments

CIG Wireless Corp (CIGW), Achillion Pharmaceuticals Inc (ACHN): Jeffrey Tannenbaum And Peter Kolchinsky Disclose Their Latest Moves

CIG Wireless Corp (OTCBB:CIGW), an operator of wireless and broadcast communication towers in the United States, has issued approximately 1.25 million...

Keep Reading →

October 2 - Hedge Funds, News - Comments

Achillion Pharmaceuticals Inc (ACHN), Tenax Therapeutics Inc (TENX): Peter Kolchinsky’s Latest Equity Moves

RA Capital Management has continued the sale of Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) shares. In a recent wave of reductions, the fund has dumped...

Keep Reading →

September 29 - Hedge Funds, News - Comments

Achillion Pharmaceuticals, Inc. (ACHN): RA Capital Management Sells Over 2 Million Shares

RA Capital Management, managed by Peter Kolchinsky, continues to unload its stake in Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN). In a new filing with...

Keep Reading →

September 24 - Hedge Funds, News - Comments

Ken Griffin

Sunesis Pharmaceuticals, Inc. (SNSS): Ken Griffin’s Citadel Boosts His Stake

Citadel Advisors, a fund managed by Ken Griffin, has disclosed boosting its stake in Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS). Citadel upped its position...

Keep Reading →

September 22 - Hedge Funds, News - Comments

Achillion Pharmaceuticals, Inc. (ACHN): Peter Kolchinsky’s RA Capital Sells Some More Shares

Peter Kolchinsky‘s RA Capital Management, in a new filing with the Securities and Exchange Commission, has disclosed the sale of around 1.70 million...

Keep Reading →

September 12 - Hedge Funds, News - Comments

RA Capital Management Continues To Unload Achillion Pharmaceuticals, Inc. (ACHN) Stock: Sells Further 835,293 Shares

In a new filing with the U.S. Securities and Exchange Commission, RA Capital Management, managed by Peter Kolchinsky, has disclosed holding an 18.1% passive...

Keep Reading →

September 4 - Hedge Funds, News - Comments

Hedge Fund News: Crispin Odey, Peter Kolchinsky & T Boone Pickens

Manchester United Divides Hedge Funds’ Loyalties (WSJ) Some of Europe’s most powerful hedge fund managers are sharply divided on the outlook...

Keep Reading →

August 28 - Hedge Funds - Comments

Achillion Pharmaceuticals Inc. (ACHN): RA Capital Management Cuts Stake To 19.0% From 21.1%

RA Capital Management, led by Peter Kolchinsky, disclosed in a newly amended filing with the U.S. Securities and Exchange Commission that it further reduced...

Keep Reading →

August 28 - Hedge Funds, News - Comments

Cognizant Technology Solutions Corp (CTSH), Titan International Inc. (TWI), Salix Pharmaceuticals Ltd. (SLXP) Among Stocks Hedge Funds Are Bullish On

Amidst the 13F filing season, several hedge funds have also been filing Schedule 13G forms, disclosing changes that took place after June 30, 2014, in...

Keep Reading →

August 21 - Hedge Funds, News - Comments

Billionaire Ken Griffin's Top 10 Stocks Holdings

Hedge Fund Highlights: Ken Griffin, Paul Tudor Jones & Bill Ackman

Citadel’s Griffin Defends HFT (FINalternatives) Citadel Investment Group founder Kenneth Griffin yesterday urged Congress not to ban high-frequency...

Keep Reading →

July 9 - Hedge Funds - Comments

RA Capital Management Sells 800,000 Shares of Achillion Pharmaceuticals Inc. (ACHN)

RA Capital Management, managed by Peter Kolchinsky, has sold 800,000 shares of Achillion Pharmaceuticals Inc. (NASDAQ:ACHN) in two transactions for about...

Keep Reading →

June 25 - Hedge Funds, News - Comments

James Litinsky is Bullish on Ophthotech Corp (OPHT); JHL Capital Boosts Stake in the Company

James H. Litinsky‘s JHL Capital Group has boosted its stake in Ophthotech Corp (NASDAQ:OPHT) to 1.78 million shares, a new filing with the SEC...

Keep Reading →

April 15 - Hedge Funds, News - Comments

RA Capital Reports New 5.8% Position In Recently Public Versartis Inc (VSAR)

Peter Kolchinsky’s RA Capital Management has initiated a new position in Versartis Inc (NASDAQ:VSAR). RA Capital owns 1.40 million shares of the company...

Keep Reading →

April 10 - Hedge Funds, News - Comments

« Older Entries
Insider Monkey HF Resource Center
  • Subscribe to Hedge Fund Alpha
  • How to Beat the Market by 20 Percentage Points
  • Why Track Hedge Funds?
  • Download a Free Edition!
  • Why You Should DUMP Your Hedge Funds
Top Hedge Funds
Warren Buffett

Warren Buffett

Berkshire Hathaway

$202,411,166,000

David Einhorn

David Einhorn

Greenlight Capital

$922,283,000

George Soros

George Soros

Soros Fund Management

$4,481,502,000

Jim Simons

Jim Simons

Renaissance Technologies

$115,840,763,000

Leon Cooperman

Leon Cooperman

Omega Advisors

$873,897,000

Carl Icahn

Carl Icahn

Icahn Capital LP

$19,724,532,000

Steve Cohen

Steve Cohen

Point72 Asset Management

$15,331,618,000

John Paulson

John Paulson

Paulson & Co

$3,129,243,000

David Tepper

David Tepper

Appaloosa Management LP

$5,758,450,000

Paul Tudor Jones

Paul Tudor Jones

Tudor Investment Corp

$2,017,669,000

Insider Monkey Small Cap Strategy
Most Read Posts
Dump Your Hedge Funds and Buy This Stock
World’s Most Expensive Desserts
The 10 Best Selling Products Online
The 10 Best Selling Items on Etsy
The 12 Most Profitable Small Businesses
The 10 Best-Selling Video Games of All Time
Lists

15 Largest Cruise Companies in the World

5 Largest Cruise Companies in the World

Top 15 Emerging Companies In India

Top 5 Emerging Companies In India

15 Biggest Renewable Energy Companies and Stocks

5 Biggest Renewable Energy Companies and Stocks

15 Fastest Growing Biotech Companies in the US

5 Fastest Growing Biotech Companies in the US

15 Most Valuable Alcohol Companies

5 Most Valuable Alcohol Companies

15 Most Valuable Asian Companies

5 Most Valuable Asian Companies

20 Most Valuable Companies In The World in February 2021

Top 15 Pharmaceutical Companies With Highest R&D Spending

Top 5 Financial Centers/Cities of The World

Top 15 Financial Centers/Cities of The World

15 Most Valuable Cloud Computing Companies

5 Most Valuable Cloud Computing Companies

15 Fastest-Growing Fintech Companies

5 Fastest-Growing Fintech Companies

15 Biggest Companies That Accept Bitcoin

15 Youngest Tech Billionaires

Top 15 Serial Entrepreneurs In The World

15 Most Powerful and Influential Companies

12 Most Influential Entrepreneurs in America

15 Richest People in Central and South America

10 Emerging Energy Technologies You Can Invest In Today

15 Richest People In Canada

15 Biggest Water Companies in the World

15 Biggest Acquisitions Of All Time

15 Fastest Growing Dividend Stocks

15 Biggest VC Companies in the World

5 Biggest VC Companies in the World

15 Biggest Trucking Companies in the World

15 Biggest Tech Hardware Companies in the World

5 Biggest Tech Hardware Companies in the World

15 Biggest Wine Companies in the World

25 Highest Earning Billionaires in 2020

15 Fastest-Growing Software Companies

15 Biggest Yogurt Companies in the World

Easily Digestible and Delicious Recipes For Elderly

5 Fastest-Growing Software Companies

5 Fastest-Growing Engineering Fields

15 Biggest Lithium Mining Companies in the World

15 Fastest-Growing Engineering Fields

15 Biggest Companies That Went Bankrupt

Top 10 Most Deadliest and Dangerous Snakes In the World

20 Most Deadliest and Dangerous Snakes In the World

10 Easiest Occupational Therapy Schools To Get Into

Top 5 Easiest Occupational Therapy Schools To Get Into

Read Me
  • 10 Strategies Hedge Funds Use To Make Huge Returns
  • 5 Best Poker Books For Beginners
  • 15 Highest Grossing Movies Opening Weekend
  • Top 10 Genetically Modified Food In the US
  • 10 Best Places To Visit In Canada
  • Best Summer Jobs For Teachers
  • Top 10 Fast Food Franchises To Buy
  • 10 Youngest Hedge Fund Billionaires
  • Top 10 One Hit Wonders of The 90s
  • Fastest Growing Cities In America
  • 10 Places To Visit Before You Die
  • Best Places To Visit In The USA
  • 10 Most Powerful Countries In The World
  • 25 Best Star Wars Video Games Of All Time
  • Top 10 Richest Cities In The World
  • 10 Most Expensive Homes In The World
  • Best Summer Jobs For College Students
  • 20 Best TED Talks Of All Time
  • 8 Most Corrupt Countries In The World
  • 10 Most Expensive Cities In The World
  • 6 Longest Prison Sentences Ever Given
  • 10 Most Profitable Franchises in 2014
  • 10 Best Warren Buffett Quotes On Life, Investing
  • 10 Most Profitable Small Businesses
  • Top 10 Paid Apps For iPhone 5
Blogroll
  • Acting Man
  • Crackerjack Finance
  • Dividend Monk
  • Farmer's TSX Dividend Listing
  • Pension Pulse
Home Hedge Funds Markets Blog Site Map
Authors About Us Contact Us Privacy Policy Terms of Use CCPA - Do Not Sell My Information
All text and design is copyright ©2021 Koala Guide LLC. All rights reserved.